Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial

Ruiter Silva Ferreira, Carlos Arturo D'Ancona, Matthias Oelke, Mauricio Rassi Carneiro

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbereAO4207
Number of pages7
JournalEinstein (São Paulo, Brazil)
Volume16
Issue number3
DOIs
Publication statusPublished - 1 Jul 2018

Keywords

  • Mandelic acids
  • Botulinum toxins, type A
  • Urinary bladder, neurogenic
  • Spinal cord injury
  • Urodynamics
  • Quality of life
  • BOTULINUM-TOXIN-A
  • QUALITY-OF-LIFE
  • PLACEBO-CONTROLLED TRIAL
  • SPINAL-CORD-INJURY
  • URINARY-INCONTINENCE
  • DOUBLE-BLIND
  • BLADDER
  • TOLERABILITY
  • MUSCLE

Cite this